{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:35:00Z","timestamp":1767706500435},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China-Major Project","award":["91957208"],"award-info":[{"award-number":["91957208"]}]},{"name":"Grant from the central guide on local science and technology development Fund of XINJIANG Province","award":["ZYYD2022A01"],"award-info":[{"award-number":["ZYYD2022A01"]}]},{"name":"Grant from the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund","award":["SKL-HIDCA-2021- XXG2"],"award-info":[{"award-number":["SKL-HIDCA-2021- XXG2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: VT (Ventricular Thrombus) is a serious complication of dilated cardiomyopathy (DCM). Our goal is to develop a nomogram for personalized prediction of incident VT in DCM patients. Methods: 1267 patients (52.87\u2009\u00b1\u200911.75 years old, 73.8% male) were analyzed retrospectively from January 01, 2015, to December 31, 2020. A nomogram model for VT risk assessment was established using minimum absolute contraction and selection operator (LASSO) and multivariate logistic regression analysis, and its effectiveness was validated by internal guidance. The model was evaluated by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). We compared the performance in predicting VT between nomogram and CHA2DS2, CHA2DS2- VASc or ATRIA by AUC, akaike information criterion (AIC), bayesian information criterion (BIC), net reclassification index (NRI), and integrated discrimination index (IDI). Results: 89 patients (7.02%) experienced VT. Multivariate logistic regression analysis revealed that age, left ventricular ejection fraction (LVEF), uric acid (UA), N-terminal precursor B-type diuretic peptide (NT-proBNP), and D-dimer (DD) were important independent predictors of VT. The nomogram model correctly separates patients with and without VT, with an optimistic C score of 0.92 (95%CI: 0.90\u20130.94) and good calibration (Hosmer-Lemeshow \u03c7<jats:sup>2<\/jats:sup>\u2009=\u200911.51, <jats:italic>P<\/jats:italic>\u2009=\u20090.12). Our model showed improved prediction of VT compared to CHA2DS2, CHA2DS2-VASc or ATRIA (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Conclusions: The novel nomogram demonstrated better than presenting scores and showed an improvement in predicting VT in DCM patients.<\/jats:p>","DOI":"10.1007\/s11239-023-02846-2","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T20:19:31Z","timestamp":1687551571000},"page":"29-38","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A nomogram to predict ventricular thrombus in dilated cardiomyopathy patients"],"prefix":"10.1007","volume":"57","author":[{"given":"Xiao-Lei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilare","family":"Adi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aibibanmu","family":"Aizezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munawar","family":"Kerem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"issue":"2","key":"2846_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1378\/chest.117.2.314","volume":"117","author":"ND Sharma","year":"2000","unstructured":"Sharma ND, McCullough PA, Philbin EF, Weaver WD (2000) Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest 117(2):314\u2013320. https:\/\/doi.org\/10.1378\/chest.117.2.314","journal-title":"Chest"},{"issue":"1","key":"2846_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ahj.2005.08.021","volume":"152","author":"MB Srichai","year":"2006","unstructured":"Srichai MB, Junor C, Rodriguez LL, Stillman AE, Grimm RA, Lieber ML et al (2006) Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 152(1):75\u201384. https:\/\/doi.org\/10.1016\/j.ahj.2005.08.021","journal-title":"Am Heart J"},{"issue":"23","key":"2846_CR3","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M et al (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37(23):1850\u20131858. https:\/\/doi.org\/10.1093\/eurheartj\/ehv727","journal-title":"Eur Heart J"},{"issue":"10092","key":"2846_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub RG, Semsarian C, Macdonald P (2017) Dilated cardiomyopathy. Lancet 390(10092):400\u2013414. https:\/\/doi.org\/10.1016\/S0140-6736(16)31713-5","journal-title":"Lancet"},{"issue":"1","key":"2846_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0002-8703(92)90757-m","volume":"123","author":"RH Falk","year":"1992","unstructured":"Falk RH, Foster E, Coats MH (1992) Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 123(1):136\u2013142. https:\/\/doi.org\/10.1016\/0002-8703(92)90757-m","journal-title":"Am Heart J"},{"issue":"2","key":"2846_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00246-009-9602-3","volume":"31","author":"SH Choi","year":"2010","unstructured":"Choi SH, Jeong SI, Yang JH, Kang IS, Jun TG, Lee HJ et al (2010) A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy. Pediatr Cardiol 31(2):264\u2013269. https:\/\/doi.org\/10.1007\/s00246-009-9602-3","journal-title":"Pediatr Cardiol"},{"issue":"9","key":"2846_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.neurol.2019.02.004","volume":"175","author":"YN Mapoure","year":"2019","unstructured":"Mapoure YN, Kamdem F, Akeyeh FJ, Dzudie A, Mouliom S, Mouelle AS et al (2019) Cardio-embolic stroke: Lessons from a single centre in Sub-Saharan Africa. Rev Neurol (Paris) 175(9):544\u2013551. https:\/\/doi.org\/10.1016\/j.neurol.2019.02.004","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"2846_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.carpath.2011.11.005","volume":"21","author":"P Vaideeswar","year":"2012","unstructured":"Vaideeswar P, Divate S, Harke M (2012) Intracardiac thrombi in extracardiac disorders: an autopsy study. Cardiovasc Pathol 21(2):e1\u20139. https:\/\/doi.org\/10.1016\/j.carpath.2011.11.005","journal-title":"Cardiovasc Pathol"},{"issue":"14","key":"2846_CR9","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2020.01.057","volume":"75","author":"B Lattuca","year":"2020","unstructured":"Lattuca B, Bouziri N, Kerneis M, Portal JJ, Zhou J, Hauguel-Moreau M et al (2020) Antithrombotic therapy for patients with left ventricular mural Thrombus. J Am Coll Cardiol 75(14):1676\u20131685. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.057","journal-title":"J Am Coll Cardiol"},{"key":"2846_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3969\/j.issn.1000-3614.2021.12.002","volume":"36","author":"Precision Cardiovascular Medicine Branch of China International Exchange and Promotive Association for Medical and HealthCare","year":"2021","unstructured":"Precision Cardiovascular Medicine Branch of China International Exchange and Promotive Association for Medical and HealthCare (2021) Cardiomyopathy CECTFoATf. Chinese Expert Consensus on the anticoagulant therapy for patients with cardiomyopathy. Chin Circulation J 36:1148\u20131157. https:\/\/doi.org\/10.3969\/j.issn.1000-3614.2021.12.002","journal-title":"Chin Circulation J"},{"key":"2846_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.13201\/j.issn.1001-1439.2018.05.001","volume":"34","author":"CDB Chinese Medical Association","year":"2018","unstructured":"Chinese Medical Association CDB, Group CMCC (2018) Chinese guidelines for the diagnosis and treatment of dilated cardiomyopathy. J Clin Cardiol (China) 34:421\u2013434. https:\/\/doi.org\/10.13201\/j.issn.1001-1439.2018.05.001","journal-title":"J Clin Cardiol (China)"},{"issue":"4","key":"2846_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.amjcard.2015.05.010","volume":"116","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhang Z, Ng CY, Li G, Liu T (2015) Meta-analysis of CHADS2 score in Predicting Atrial Fibrillation. Am J Cardiol 116(4):554\u2013562. https:\/\/doi.org\/10.1016\/j.amjcard.2015.05.010","journal-title":"Am J Cardiol"},{"issue":"5","key":"2846_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"2846_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijcard.2016.11.015","volume":"227","author":"W Zhu","year":"2017","unstructured":"Zhu W, Fu L, Ding Y, Huang L, Xu Z, Hu J et al (2017) Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation. Int J Cardiol 227:436\u2013442. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.015","journal-title":"Int J Cardiol"},{"issue":"2","key":"2846_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/ehjcvp\/pvaa066","volume":"7","author":"M Massussi","year":"2021","unstructured":"Massussi M, Scotti A, Lip GYH, Proietti R (2021) Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother 7(2):158\u2013167. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa066","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2846_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3969\/j.issn.1000-3614.2021.06.005","volume":"36","author":"M Zhai","year":"2021","unstructured":"Zhai M, Huang L, Wang Y, Zhang Y, Zhang J (2021) Clinical characteristics of patients with dilated cardiomyopathy complicating with intracardiac Thrombus. Chin Circulation J 36:563\u2013566. https:\/\/doi.org\/10.3969\/j.issn.1000-3614.2021.06.005","journal-title":"Chin Circulation J"},{"key":"2846_CR17","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3760\/cma.j.issn.0376-2491.2019.45.011","volume":"99","author":"Z Hu","year":"2019","unstructured":"Hu Z, Wu L, Liu S, Shen L, Zhao M, Liu L et al (2019) Clinical characteristics of cardiomyopathies complicated with ventricular thrombosis. Zhonghua Yi Xue Za Zhi 99:3587\u20133591. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2019.45.011","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"2846_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ehf2.13211","volume":"8","author":"AI Lemaitre","year":"2021","unstructured":"Lemaitre AI, Picard F, Maurin V, Faure M, Dos Santos P, Girerd N (2021) Clinical profile and midterm prognosis of left ventricular thrombus in heart failure. ESC Heart Fail 8(2):1333\u20131341. https:\/\/doi.org\/10.1002\/ehf2.13211","journal-title":"ESC Heart Fail"},{"issue":"19","key":"2846_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","volume":"70","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in Context: D-Dimer. J Am Coll Cardiol 70(19):2411\u20132420. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.024","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2846_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1161\/Strokeaha.118.021899","volume":"49","author":"Y Hamatani","year":"2018","unstructured":"Hamatani Y, Nagai T, Nakai M, Nishimura K, Honda Y, Nakano H et al (2018) Elevated plasma D-Dimer level is Associated with Short-Term risk of ischemic stroke in patients with Acute Heart failure. Stroke 49(7):1737\u20131740. https:\/\/doi.org\/10.1161\/Strokeaha.118.021899","journal-title":"Stroke"},{"issue":"12","key":"2846_CR21","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.hrthm.2021.08.027","volume":"18","author":"C Diaz-Arocutipa","year":"2021","unstructured":"Diaz-Arocutipa C, Gonzales-Luna AC, Branez-Condorena A, Hernandez AV (2021) Diagnostic accuracy of D-dimer to detect left atrial thrombus in patients with atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 18(12):2128\u20132136. https:\/\/doi.org\/10.1016\/j.hrthm.2021.08.027","journal-title":"Heart Rhythm"},{"issue":"4","key":"2846_CR22","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.18632\/aging.202458","volume":"13","author":"XD Zhou","year":"2021","unstructured":"Zhou XD, Yu LF, Hu WZ, Shi RY, Ji YN, Zhou CZ et al (2021) A novel risk model to predict first-ever ischemic stroke in heart failure with reduced ejection fraction. Aging-Us 13(4):5332\u20135341 :\/\/WOS:000624639700012","journal-title":"Aging-Us"},{"issue":"1","key":"2846_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jth.15139","volume":"19","author":"L De Lucchi","year":"2021","unstructured":"De Lucchi L, Nardin C, Sponchiado A, Raggi D, Faggin E, Martini E et al (2021) Serum uric acid levels and the risk of recurrent venous thromboembolism. J Thromb Haemost 19(1):194\u2013201. https:\/\/doi.org\/10.1111\/jth.15139","journal-title":"J Thromb Haemost"},{"issue":"3\u20134","key":"2846_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00508-020-01802-x","volume":"134","author":"M Lucijanic","year":"2022","unstructured":"Lucijanic M, Krecak I, Galusic D, Sedinic M, Holik H, Perisa V et al (2022) Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis. Wien Klin Wochenschr 134(3\u20134):97\u2013103. https:\/\/doi.org\/10.1007\/s00508-020-01802-x","journal-title":"Wien Klin Wochenschr"},{"key":"2846_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijcard.2018.01.080","volume":"258","author":"FZ Liu","year":"2018","unstructured":"Liu FZ, Liao HT, Lin WD, Xue YM, Zhan XZ, Fang XH et al (2018) Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients. Int J Cardiol 258:103\u2013108. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.080","journal-title":"Int J Cardiol"},{"key":"2846_CR26","doi-asserted-by":"publisher","unstructured":"Tapoi L, Salaru DL, Sascau R, Statescu C (2021) Uric Acid-An Emergent risk marker for thrombosis? J Clin Med 10(10). https:\/\/doi.org\/10.3390\/jcm10102062","DOI":"10.3390\/jcm10102062"},{"issue":"4","key":"2846_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.12669\/pjms.36.4.1972","volume":"36","author":"NN Aljaber","year":"2020","unstructured":"Aljaber NN, Mattash ZA, Alshoabi SA, Alhazmi FH (2020) The prevalence of left ventricular thrombus among patients with low ejection fraction by trans-thoracic echocardiography. Pak J Med Sci 36(4):673\u2013677. https:\/\/doi.org\/10.12669\/pjms.36.4.1972","journal-title":"Pak J Med Sci"},{"issue":"14","key":"2846_CR28","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2020.01.057","volume":"75","author":"B Lattuca","year":"2020","unstructured":"Lattuca B, Bouziri N, Kerneis M, Portal JJ, Zhou JN, Hauguel-Moreau M et al (2020) Antithrombotic therapy for patients with left ventricular mural Thrombus. J Am Coll Cardiol 75(14):1676\u20131685. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.057","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2846_CR29","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.jacc.2019.01.031","volume":"73","author":"CP McCarthy","year":"2019","unstructured":"McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG et al (2019) Left ventricular Thrombus contemporary etiologies, treatment strategies, and outcomes. J Am Coll Cardiol 73(15):2007\u20132009. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.031","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2846_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10557-020-07011-y","volume":"34","author":"WG Zhu","year":"2020","unstructured":"Zhu WG, Wu YZ, Zhou YY, Liang WH, Xue RC, Wu ZX et al (2020) CHA2DS2-VASc and ATRIA scores and clinical outcomes in patients with heart failure with preserved ejection fraction. Cardiovasc Drug Ther 34(6):763\u2013772. https:\/\/doi.org\/10.1007\/s10557-020-07011-y","journal-title":"Cardiovasc Drug Ther"},{"issue":"1","key":"2846_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12872-019-1178-0","volume":"19","author":"MK Son","year":"2019","unstructured":"Son MK, Lim NK, Park HY (2019) Predicting stroke and death in patients with heart failure using CHA2DS2-VASc score in Asia. BMC Cardiovasc Disord 19(1):193. https:\/\/doi.org\/10.1186\/s12872-019-1178-0","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02846-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02846-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02846-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T13:09:08Z","timestamp":1706706548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02846-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2846"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02846-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"5 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the Declaration of Helsinki and the study protocol was approved by the ethics committees of the First Affiliated Hospital of Xinjiang Medical University (K202203-17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Because of the retrospective design of this study, the need to obtain informed consent from eligible patients was waived by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}